IO, South Tangerang – Innovation and research in healthcare fields, especially in pharmaceutics are still lacking in Indonesia. To drive interest in the field, PT Dexa Medica is handing out the Dexa Award Science Scholarship (DASS) to gifted university students. The scholarship, aimed at helping university students obtain their Master’s Degree, is open to students who submit research proposals related to healthcare, where results could be used to improve public health.
The DASS 2019 scholarship program started with the announcement of registration and submission of proposals, which took place from February 1, 2019, to April 15, 2019. The DASS committee received 1,664 submissions during the eight-week timespan. Submissions came from 34 provinces, 295 cities/districts, and 349 campuses across Indonesia.
From the thousands of students who registered, the board of juries, which consisted of five scientists from public universities across Indonesia, chose ten finalists and three winners. The three winners were Yesiska K Hartanti from Universitas Gadjah Mada, Yogyakarta; M. Rezki from Universitas Diponegoro, Semarang; and Yayan D. Sutarni from Universitas Sebelas Maret (UNS), Solo. The winners received a Rp 300 million scholarship to be used to earn their Master’s Degree and were free to choose at any A-accredited university.
CEO Dexa Group Ferry Soetikno stated that research in the pharmaceutical sector in Indonesia still needed to be further developed, such as to increase the use of native Indonesian natural materials for fitofarmaka, a traditional medicine category which has gone through clinical trials to ensure its safety and efficacy. “The raw materials used for medicine used so far are mostly still imported. Since 2005, Dexa has been researching native Indonesian materials and have so far created ten fitofarmaka products. “One by one, natural local ingredients are being pushed to replace imported products,” said Ferry to reporters during the scholarship awarding ceremony in South Tangerang, Thursday (27/6/2019).
DASS 2019 committee head Dr. Raymond Tjandrawinata added that ideas from academicians were very much needed to develop more innovative products for the pharmaceutical industry. (est)